| Dr Steven Eric Schneider, MD | |
|
64 Robbins St, Waterbury, CT 06708-2613 | |
| (203) 573-7141 | |
| (203) 573-6161 |
| Full Name | Dr Steven Eric Schneider |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 64 Robbins St, Waterbury, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043464159 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 024765 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Steven Eric Schneider, MD 64 Robbins St., Waterbury, CT 06708-2613 Ph: (203) 573-7141 | Dr Steven Eric Schneider, MD 64 Robbins St, Waterbury, CT 06708-2613 Ph: (203) 573-7141 |
News Archive
University of Miami researchers have shown that drinking enough water can halve the risk of developing a UTI in pre-menopausal women.
People age in different ways. Biological age is a metric that scientists use to predict health risks, the relevance of which can be enhanced by combining different markers. Particularly important markers are frailty and the epigenetic clock, write researchers from Karolinska Institutet in a study published in eLife.
Nabi Biopharmaceuticals today announced its first quarter financial results for the three month period ended March 27, 2010. The Company reported net income from continuing operations of $5.5 million, or $0.11 per share, compared to a net loss of $7.0 million, or $0.14 per share, for the period ended March 28, 2009.
To protect human health, Endocrine Society members called on the European Commission to adopt science-based policies for regulating endocrine-disrupting chemicals in an opinion piece published today in The Lancet Diabetes & Endocrinology.
Sepracor Inc. announced today the preliminary results of a large-scale, 671-patient Phase III study of OMNARIS® (ciclesonide) HFA, an aerosol nasal formulation of ciclesonide, for the treatment of seasonal allergic rhinitis (SAR) in adult and adolescent patients. In this study, OMNARIS HFA met its primary efficacy endpoint by demonstrating a statistically significant reduction versus placebo in the reflective total nasal symptom score averaged over a two-week treatment period.
› Verified 7 days ago
Eleanor Elizabeth Stutz, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 95 Thomaston Ave, Dmhas - Wcmhn, Waterbury, CT 06702 Phone: 203-805-5300 Fax: 203-805-5310 | |
Judith Karen Carlson, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 55 West Main Street Suite 410, Western Connecticut Mental Health Network, Waterbury, CT 06702 Phone: 203-805-6408 Fax: 203-805-6432 | |
Dr. Jeffrey Howard Boyd, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 969 W Main St, Waterbury, CT 06708 Phone: 203-573-8555 Fax: 203-597-9565 | |
Rosina I Bandanza, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 95 Thomaston Ave, Western Connecticut Menatl Health Network, Waterbury, CT 06702 Phone: 203-805-5300 Fax: 203-805-5310 | |
Alok Bhargava, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 134 Grandview Ave, Suite 208, Waterbury, CT 06708 Phone: 203-755-3279 Fax: 203-755-3057 | |
Sabooh Mubbashar, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 64 Robbins St, Crisis Intervention Center, Waterbury, CT 06708 Phone: 203-573-6500 Fax: 203-573-7007 |